Non-invasive Vagus Nerve Stimulation in Patients Undergoing Electrophysiological Study

Running, not enrolling · Not applicable

Conditions studied: Neuromodulation

In brief

The Non-invasive Vagus Nerve Stimulation in Patients Undergoing Electrophysiological Study is a single center, pilot, prospective study that aims at evaluating the effects of auricular vagus nerve stimulation (aVNS) on the human cardiac conduction system.

Key facts

Study ID

NCT05350150

Run by

Northwell Health

People needed

10

Starts

2022-08-22

Expected to finish

2026-07-30

Last updated by the study team

2026-04-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Primary indication for EPS for the evaluation of cardiac conduction system or supraventricular tachycardia.

You may not qualify if…

• Previous EPS with ablation
• Previous failed ablation
• Known conduction system disease, right or left bundle branch block on EKG
• Pregnant women
• History of postural orthostatic tachycardia syndrome
• Patients who have had prior cervical vagotomy
• Patients with skin on the tragus that is broken or cracked
• Patients with a history of baseline cardiac disease or atherosclerotic cardiovascular disease, including congestive heart failure (CHF), known severe coronary artery disease or recent myocardial infarction (within 5 years) and patients diagnosed with narrowing of the arteries (carotid atherosclerosis)
• Patients with an active implantable medical device, such as a cardiac pacemaker, hearing aid implant, or any implanted metallic, implanted vagus nerve stimulator or electronic device.

Where it is running

• Kristie Coleman — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.